Show simple item record

Presentation

dc.creatorPachón Ibáñez, María Eugeniaes
dc.creatorDocobo Pérez, Fernandoes
dc.creatorBlanquero Bravo, Rafaeles
dc.creatorGarnacho Montero, Josées
dc.creatorBenítez Peña, Sandraes
dc.creatorDimopoulos, Georgees
dc.creatorRosso Fernández, Claraes
dc.creatorGutiérrez Pizarraya, Antonioes
dc.creatorLópez Cortés, Luis Fernandoes
dc.creatorCisneros Herreros, José Migueles
dc.date.accessioned2017-09-08T10:29:24Z
dc.date.available2017-09-08T10:29:24Z
dc.date.issued2016
dc.identifier.citationPachón Ibáñez, M.E., Docobo Pérez, F., Blanquero Bravo, R., Garnacho Montero, J., Benítez Peña, S., Dimopoulos, G.,...,Cisneros Herreros, J.M. (2016). Population pharmacokinetics of colistin: implications for clinical use for Gram-negative pathogens. En 26th European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam.
dc.identifier.urihttp://hdl.handle.net/11441/64282
dc.description.abstractThe objective of this study was to characterize the pharmacokinetics of colistin methanesulphonate (CMS) and colistin in critically ill patients following the administration of a 4.5 MU CMS loading dose follow by 3MU CMS Q8. A population PK model and Monte Carlo simulation were used to calculate the probability of target attainment (PTA) against Acinetobacter baumannii and Pseudomonas aeruginosa by considering a range of MIC values seen in the clinic.es
dc.formatapplication/pdfes
dc.language.isoenges
dc.relation.ispartof26th European Congress of Clinical Microbiology and Infectious Diseases (2016).
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titlePopulation pharmacokinetics of colistin: implications for clinical use for Gram-negative pathogenses
dc.typeinfo:eu-repo/semantics/conferenceObjectes
dc.type.versioninfo:eu-repo/semantics/submittedVersiones
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Estadística e Investigación Operativaes
dc.contributor.groupUniversidad de Sevilla. FQM329: Optimizaciónes
dc.contributor.groupUniversidad de Sevilla. CTS210: Adherencia Bacteriana a Nuevos Biomaterialeses
idus.format.extent1 p.es
dc.eventtitle26th European Congress of Clinical Microbiology and Infectious Diseaseses
dc.eventinstitutionAmsterdames

FilesSizeFormatViewDescription
Population pharmacokinetics of ...217.2KbIcon   [PDF] View/Open  

This item appears in the following collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as: Attribution-NonCommercial-NoDerivatives 4.0 Internacional